These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 16886975

  • 1. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study.
    Ramael S, Daoust A, Otoul C, Toublanc N, Troenaru M, Lu ZS, Stockis A.
    Epilepsia; 2006 Jul; 47(7):1128-35. PubMed ID: 16886975
    [Abstract] [Full Text] [Related]

  • 2. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S, De Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen JM, Stockis A.
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [Abstract] [Full Text] [Related]

  • 3. Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics.
    Patterson EE, Goel V, Cloyd JC, O'Brien TD, Fisher JE, Dunn AW, Leppik IE.
    J Vet Pharmacol Ther; 2008 Jun; 31(3):253-8. PubMed ID: 18471147
    [Abstract] [Full Text] [Related]

  • 4. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures.
    Baulac M, Brodie MJ, Elger CE, Krakow K, Stockis A, Meyvisch P, Falter U.
    Epilepsia; 2007 Mar; 48(3):589-92. PubMed ID: 17326794
    [Abstract] [Full Text] [Related]

  • 5. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J, Coetzee C, Jiménez F, Litovchenko T, Ramaratnam S, Zaslavaskiy L, Lu ZS, Sykes DM, Levetiracetam XR N01235 Study Group.
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [Abstract] [Full Text] [Related]

  • 6. Levetiracetam pharmacokinetics in healthy dogs following oral administration of single and multiple doses.
    Moore SA, Muñana KR, Papich MG, Nettifee-Osborne J.
    Am J Vet Res; 2010 Mar; 71(3):337-41. PubMed ID: 20187836
    [Abstract] [Full Text] [Related]

  • 7. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R, Rosillon D, Bridson WE, Meeus MA, Salas E, Stockis A.
    Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
    [Abstract] [Full Text] [Related]

  • 8. Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus.
    Uges JW, van Huizen MD, Engelsman J, Wilms EB, Touw DJ, Peeters E, Vecht CJ.
    Epilepsia; 2009 Mar; 50(3):415-21. PubMed ID: 19054418
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
    Lim KS, Kim JR, Choi YJ, Shin KH, Kim KP, Hong JH, Cho JY, Shin HS, Yu KS, Shin SG, Kwon OH, Hwang DM, Kim JA, Jang IJ.
    Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
    [Abstract] [Full Text] [Related]

  • 10. Oral absorption kinetics of levetiracetam: the effect of mixing with food or enteral nutrition formulas.
    Fay MA, Sheth RD, Gidal BE.
    Clin Ther; 2005 May; 27(5):594-8. PubMed ID: 15978308
    [Abstract] [Full Text] [Related]

  • 11. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ, Somerville ER, Van Paesschen W, Ryvlin P, Schelstraete I.
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [Abstract] [Full Text] [Related]

  • 12. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY, Hong Z, Wu X, Wu LW, Wang XF, Zhou D, Zhao ZX, Lv CZ.
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses.
    Herman GA, Stevens C, Van Dyck K, Bergman A, Yi B, De Smet M, Snyder K, Hilliard D, Tanen M, Tanaka W, Wang AQ, Zeng W, Musson D, Winchell G, Davies MJ, Ramael S, Gottesdiener KM, Wagner JA.
    Clin Pharmacol Ther; 2005 Dec; 78(6):675-88. PubMed ID: 16338283
    [Abstract] [Full Text] [Related]

  • 14. Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using meta-analytic techniques.
    Richy FF, Banerjee S, Brabant Y, Helmers S.
    Epilepsy Behav; 2009 Oct; 16(2):240-5. PubMed ID: 19699156
    [Abstract] [Full Text] [Related]

  • 15. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study.
    Wheless JW, Clarke D, Hovinga CA, Ellis M, Durmeier M, McGregor A, Perkins F.
    J Child Neurol; 2009 Aug; 24(8):946-51. PubMed ID: 19264738
    [Abstract] [Full Text] [Related]

  • 16. Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial.
    Genton P, Sadzot B, Fejerman N, Peltola J, Despland PA, Steinhoff B, Rektor I, Wroe S, Maubrey MC, Vandervelden C, van Hammée G, Schlit AF, van Paesschen W.
    Acta Neurol Scand; 2006 Jun; 113(6):387-94. PubMed ID: 16674605
    [Abstract] [Full Text] [Related]

  • 17. Modeling and simulation of intravenous levetiracetam pharmacokinetic profiles in children to evaluate dose adaptation rules.
    Snoeck E, Jacqmin P, Sargentini-Maier ML, Stockis A.
    Epilepsy Res; 2007 Sep; 76(2-3):140-7. PubMed ID: 17851036
    [Abstract] [Full Text] [Related]

  • 18. Intravenous levetiracetam for epileptic seizure emergencies in older people.
    Beyenburg S, Reuber M, Maraite N.
    Gerontology; 2009 Sep; 55(1):27-31. PubMed ID: 18953167
    [Abstract] [Full Text] [Related]

  • 19. Ghrelin agonist (TZP-101): safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study.
    Lasseter KC, Shaughnessy L, Cummings D, Pezzullo JC, Wargin W, Gagnon R, Oliva J, Kosutic G.
    J Clin Pharmacol; 2008 Feb; 48(2):193-202. PubMed ID: 18199894
    [Abstract] [Full Text] [Related]

  • 20. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
    Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Orman CB, Gauer LJ, Lu Z, N159 Study Group.
    Neurology; 2006 Jun 13; 66(11):1654-60. PubMed ID: 16641323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.